Announcing “Ask Us Anything”

AskAnythingWeb

Announcing Ask Us Anything, a Virtual Entrepreneur or Subject Matter Expert Form. This is our “Ask Amy” or “GQ Style Guy” equivalent. It is a forum for current, would be, and want to be entrepreneurs to ask any and all questions relating to the community, being an entrepreneur and starting up a company.

Your questions can be anonymous, so ask all of those little questions you have always wanted to ask. We will go out and find the right expert to answer your question and post the responses every week.

Continue reading

WhiteCityNews Podcast with Gretchen Johnson, President & CEO, TRACT Therapeutics, Inc.

Gretchenpod

I had the chance to sit down with Chicago serial entrepreneur, Gretchen Johnson. We talked about her new company TRACT Therapeutics, how a unquenchable desire for challenge has driven her career, and Gretchen shares her advice to current and would-be entrepreneurs.

Framing Up Capital Efficiency In Early Stage Biotech

Originally posted on Forbes

95012103-e1403297793936-1024x767

Capital efficiency has become a mantra at Atlas, one shared by a number of other early stage biotech investors. It’s a term often repeated in discussions about building young companies, and yet it has become clear that there’s no consistent definition of what the term means.

Continue reading

5 considerations for potential bootstrappers

bootstrap

Dreams of starting your own business are often filled with fantasies of coming up with a great idea, and venture capital firms fighting to fund it for you.

But as Bill Reichert of Garage Technology Ventures puts it: “The odds of raising venture capital are equal to the odds of getting struck by lightning while standing on the bottom of a swimming pool on a sunny day.”

Continue reading

Growing an Illinois VC community, our neighbors may provide a model

 

michigan-pier3

A July 5th article in Crain’s Chicago, “Plant venture seeds with Midwest capital” claimed that all of the seeds are in place to make Chicago a hub of entrepreneurial innovation.

Illinois does have globally competitive universities; big corporations investing in innovation; a raft of business incubators and accelerator programs; serial entrepreneurs eager to mentor and mentoring programs to leverage this new pool of entrepreneurs; government partners willing to lend a hand; recognized Chicago-grown companies drawing investor interest and serving as a proving ground for young talent; and enthusiastic early stage investors who want to help founders develop their ideas.

Continue reading

How an inventor’s trying to cut the cost of making biological drugs

Therapeutic Protein's CEO, Sarfaraz K. Niazi

Therapeutic Protein’s CEO, Sarfaraz K. Niazi

The 2010 Affordable Care Act created a shorter licensing path for lower-cost versions of cell-derived drugs called biologics. Sarfaraz Niazi is working to get among the first of these substitute drugs called biosimilars approved by the U.S. Food and Drug Administration. A former Abbott Labs scientist and University of Illinois at Chicago professor, Niazi is founder, chairman and CEO of Therapeutic Proteins International LLC in Chicago. He shares how he’s taking the cost out of manufacturing biological drugs and provides advice on being a better inventor.

Read the interview on BlueSky Innovation